Drug development in pediatrics: problems and strategies. The point of view of the academic community.
作者信息
Soyka L F
出版信息
Pediatr Pharmacol (New York). 1980;1(1):21-4.
PMID:7346728
Abstract
摘要
相似文献
1
Drug development in pediatrics: problems and strategies. The point of view of the academic community.儿科药物研发：问题与策略。学术界的观点。
Pediatr Pharmacol (New York). 1980;1(1):21-4.
2
American Academy of Pediatrics. Committee on drugs. Drug testing in children: FDA regulations.美国儿科学会。药物委员会。儿童药物检测：美国食品药品监督管理局法规。
Pediatrics. 1969 Mar;43(3):463-5.
3
Drug development in pediatrics: problems and strategies. Overview and perspectives.
Pediatr Pharmacol (New York). 1980;1(1):3-5.
4
Patient recruitment: US perspective.患者招募：美国视角。
Pediatrics. 1999 Sep;104(3 Pt 2):619-22.
5
Lack of pediatric drug formulations.缺乏儿科药物制剂。
Pediatrics. 1999 Sep;104(3 Pt 2):607-9.
6
Current challenges in pediatric drug development.儿科药物研发中的当前挑战。
Clin Adv Hematol Oncol. 2008 Dec;6(12):883-4.
7
Is pediatric labeling really necessary?儿科用药标签真的有必要吗？
Pediatrics. 1999 Sep;104(3 Pt 2):593-7.
8
Optimal sampling theory: An overview of its application to pharmacokinetic studies in infants and children.
Pediatrics. 1999 Sep;104(3 Pt 2):627-32.
9
Members of new FDA board tied to industry.
J Natl Cancer Inst. 2008 Mar 5;100(5):296-7. doi: 10.1093/jnci/djn051. Epub 2008 Feb 26.
10
Evaluating drugs for use in children.
FDA Consum. 1975 Mar;9(2):14-7.
引用本文的文献
1
Drug use in non-hospitalized children.
Pharm Weekbl Sci. 1992 Feb 21;14(1):1-8. doi: 10.1007/BF01989218.
Zotero 插件